Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,980.00    -40.00 (-1.98%)
Bid:
1,972.00
Ask:
1,973.00
Spread: 1.00 (0.051%)
Market Cap: £3.32b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Johnson Matthey Clean Air roundtable

7 Feb 2022 08:00

RNS Number : 8058A
Johnson Matthey PLC
07 February 2022
 

7th February 2022

 

Johnson Matthey Plc

(the Company)

Johnson Matthey Clean Air roundtable

 

Today, Johnson Matthey will hold a Clean Air roundtable event for investors and analysts hosted by Alastair Judge, Clean Air Chief Financial Officer and Interim Chief Executive, Peter Hill, Clean Air Chief Commercial Officer and Transformation Director, and Millissa Flanagan, Clean Air Chief Operations Officer. 

 

The session aims to provide greater insight into Clean Air and its outlook for cash generation over the medium and long-term. We reiterate our cashflow target of at least £4 billion by 2030/31¹ under a range of scenarios for changes in automotive markets. We also outline our confidence in the significant profitability and cash generation of the business beyond this period. These expectations are underpinned by:

 

· Our leadership positions in the markets in which we operate

· Tightening emissions legislation globally

· Delivering on robust commercial and operational plans

· Driving cost and efficiency across our operations

· A strong team, with a breadth of automotive and transformation experience

 

The presentation materials are available on our website via the following link:

https://matthey.com/en/investors/presentations

 

Note

1. Driving at least £4 billion of cash under our range of scenarios from 1st April 2021 to 31st March 2031, as disclosed at our 2020/2021 full year results on 27th May 2021.

 

 

ENDS

 

Enquiries: 

Investor Relations

Martin Dunwoodie

Louise Curran

Carla Fabiano

 

Director of Investor Relations

Senior Investor Relations Manager

Senior Investor Relations Manager

 

+44 20 7269 8241

+44 20 7269 8235

+44 20 7269 8004

 

Media

Barney Wyld

Harry Cameron

 

 

Group Corporate Affairs Director

Tulchan Communications

 

 

+44 20 7269 8001

+44 7799 152148

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRVZLFBLLLZBBZ
Date   Source Headline
13th Nov 20204:45 pmRNSHolding(s) in Company
22nd Oct 20204:49 pmRNSDirector/PDMR Shareholding
29th Sep 20204:52 pmRNSDirector/PDMR Shareholding
21st Sep 20204:08 pmRNSDirector/PDMR Shareholding
18th Sep 20204:21 pmRNSDirector/PDMR Shareholding
18th Sep 20207:00 amRNSJohnson Matthey: Hydrogen Seminar
21st Aug 20209:05 amRNSDirector/PDMR Shareholding
11th Aug 202010:12 amRNSDoug Webb - New Directorship
6th Aug 20204:19 pmRNSDirector/PDMR Shareholding
6th Aug 20204:11 pmRNSDirector/PDMR Shareholding
5th Aug 20204:25 pmRNSDirector/PDMR Shareholding
5th Aug 20204:21 pmRNSDirector/PDMR Shareholding
5th Aug 20204:04 pmRNSDirector/PDMR Shareholding
30th Jul 20202:45 pmRNSDirector Declaration
23rd Jul 20203:25 pmRNSResult of AGM
23rd Jul 20207:00 amRNSJohnson Matthey Q1 AGM trading update
17th Jul 20201:31 pmRNSDirector/PDMR Shareholding
14th Jul 202012:18 pmRNSDirector/PDMR Shareholding
25th Jun 20207:00 amRNSAnna Manz, CFO, to leave JM and join LSEG
23rd Jun 20207:00 amRNSAnnual Financial Report
19th Jun 20203:14 pmRNSDirector/PDMR Shareholding
16th Jun 20205:13 pmRNSDirector/PDMR Shareholding
16th Jun 20209:00 amRNSCompany Secretary Change
11th Jun 20207:00 amRNSPreliminary results for year ended 31st March 2020
4th Jun 20204:35 pmRNSDirector/PDMR Shareholding
21st May 20204:08 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSJohnson Matthey revised date for full year results
28th Apr 20203:45 pmRNSRights attaching to ordinary shares
22nd Apr 20207:00 amRNSJM and COVID-19: supporting our stakeholders
16th Apr 20204:56 pmRNSDirector/PDMR Shareholding
2nd Apr 202010:31 amRNSJane Griffiths - New Directorship
1st Apr 20207:00 amRNSCompany Secretary Change
30th Mar 20207:00 amRNSJohnson Matthey pre-close trading statement
19th Mar 20203:11 pmRNSDirector/PDMR Shareholding
25th Feb 202011:04 amRNSDirector/PDMR Shareholding
20th Feb 20203:35 pmRNSDirector/PDMR Shareholding
6th Feb 20205:33 pmRNSDirector/PDMR Shareholding
6th Feb 20203:52 pmRNSDirector/PDMR Shareholding
6th Feb 20203:41 pmRNSDirector/PDMR Shareholding
6th Feb 20203:29 pmRNSDirector/PDMR Shareholding
4th Feb 20207:30 amRNSJohn O'Higgins - New Directorship
17th Jan 202010:09 amRNSDirector/PDMR Shareholding
19th Dec 20194:31 pmRNSDirector/PDMR Shareholding
26th Nov 20195:06 pmRNSHolding(s) in Company
26th Nov 20195:01 pmRNSDirector/PDMR Shareholding
26th Nov 20194:53 pmRNSDirector/PDMR Shareholding
26th Nov 20194:41 pmRNSDirector/PDMR Shareholding
25th Nov 201911:56 amRNSDirector/PDMR Shareholding
25th Nov 201910:18 amRNSDirector/PDMR Shareholding
21st Nov 20192:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.